Home › Atherosclerosis › Idaho › Meridian
Atherosclerosis clinical trials in Meridian, ID
5 studies for Atherosclerosis are looking for participants at sites in and around Meridian (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- High Desert Heart & Vascular, Meridian
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Velocity Clinical Research - Boise, Meridian
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- St. Luke's Clinic - Idaho Cardiology Associates, Meridian
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- High Desert Heart & Vascular, Meridian
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Meridian
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Meridian
- Obesity8 studies
- Overweight7 studies
- Prostate Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Non-Small Cell Lung Cancer4 studies
- Lung Cancer4 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Melanoma3 studies
- Ovarian Cancer3 studies
- Eczema3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.